When should I choose ARPA-H?

Best for bold, high-risk health platform and medtech breakthrough concepts Strong fit when the story is transformational R&D—not near-term stockpile deployment Reviewers expect audacious technical milestones with credible execution teams Often suited to earlier platform validation before procurement-style logic

When should I choose BARDA?

Best for countermeasures, diagnostics, therapeutics, and deployable health security products Strong fit when manufacturing readiness and mission impact are central Reviewers emphasize scalability, stockpile relevance, and operational timelines EZ-BAA and full solicitations support fast-turn and strategic pursuits

ARPA-H vs BARDA: Health Innovation Pathway Comparison

Compare ARPA-H and BARDA for health security and medtech teams deciding between transformational health R&D and countermeasure development pathways.

ARPA-H

Best for bold, high-risk health platform and medtech breakthrough concepts
Strong fit when the story is transformational R&D—not near-term stockpile deployment
Reviewers expect audacious technical milestones with credible execution teams
Often suited to earlier platform validation before procurement-style logic

BARDA

Best for countermeasures, diagnostics, therapeutics, and deployable health security products
Strong fit when manufacturing readiness and mission impact are central
Reviewers emphasize scalability, stockpile relevance, and operational timelines
EZ-BAA and full solicitations support fast-turn and strategic pursuits

Velawolf recommendation

Choose ARPA-H when validating a transformational health platform with high technical risk. Choose BARDA when your product logic centers on countermeasure development, manufacturing readiness, and health security deployment.